Contribution: SIF Stream3- Attraction
Medicago inc.
$169,872,474.00
Medicago Proposal to fill Canada's pandemic preparedness gap
EF 2019-20 · 2020-03-28
Résumé
The Project is in direct response to the global fight against COVID-19. The Project will be undertaken in two stages to (1) develop a plant-derived virus-like particle (VLP) vaccine for the prevention of COVID-19; and (2) establish a large-scale GMP Facility for vaccine and antibody production in Canada.
Programme
SIF Stream3- Attraction
Bénéficiaire
Emplacement
Quebec, Quebec, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
872308499
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2020-03-28 | 2019-20 | $173,000,000.00 |
| 1 | 2020-03-28 | 2019-20 | $200,000,000.00 |
| 2 | 2020-03-28 | 2019-20 | $169,872,474.00 |
Tel que publié
Agreement End Date
2024-03-31
Agreement Number
815733
Agreement Start Date
2020-03-28
Agreement Title
Medicago Proposal to fill Canada's pandemic preparedness gap
Agreement Title (French)
Proposition de Medicago pour combler les lacunes du Canada en matière de préparation aux pandémies
Agreement Type
Contribution
Agreement Value
$169,872,474.00
Amendment Date
2023-11-24
Amendment Number
2
Description
The Project is in direct response to the global fight against COVID-19. The Project will be undertaken in two stages to (1) develop a plant-derived virus-like particle (VLP) vaccine for the prevention of COVID-19; and (2) establish a large-scale GMP Facility for vaccine and antibody production in Canada.
Description (French)
Le projet se veut une réponse directe à la lutte mondiale contre la COVID-19. Le projet sera entrepris en deux étapes pour 1) mettre au point un vaccin à base de pseudoparticules virales (VLP) d'origine végétale pour prévenir la COVID-19; et 2) établir une installation de BPF à grande échelle pour la production de vaccins et d'anticorps au Canada.
Federal Riding
Louis-Hébert
Federal Riding (French)
Louis-Hébert
Federal Riding Number
24044
NAICS Code
541710
Organization Code
ic
Organization
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
Program Name
SIF Stream3- Attraction
Program Name (French)
FIS Volet3- Attraction
Program Purpose
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
Program Purpose (French)
-favoriser les activités de R-D qui accéléreront le transfert de la technologie et la commercialisation de produits, de processus et de services novateurs ;-faciliter la croissance et l'expansion des entreprises au Canada ;-attirer et conserver des investissements de grande envergure au Canada ; et-faire progresser la recherche industrielle, le développement et la démonstration de technologies grâce à la collaboration entre les universitaires, les organisations à but non lucratif et le secteur privé.
Recipient Business Number
872308499
Recipient City
Quebec
Recipient Country
CA
Recipient Legal Name
Medicago inc.
Recipient Operating Name
Medicago inc.
Recipient Postal Code
G1V3V9
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
033-2020-2021-Q3-815733
